Skip to main content
ConductScienceScienceDex

Deininger, Michael W.

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #5,378
Unclaimed recordClaim profile
  • R01 Holder

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$1.6M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#5,378
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Deininger, Michael W.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Deininger, Michael W. as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA268496-01A1R01Contact PI
    The function of MS4A3 in normal and malignant hematopoiesis
    Versiti Wisconsin, Inc.
    $466.6K
    award amount
  • 3R01CA254354-05S1R01Contact PI
    Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia
    Versiti Wisconsin, Inc.
    $371.3K
    award amount
  • 5R01CA257602-03R01Contact PI
    Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL
    Versiti Wisconsin, Inc.
    $369.9K
    award amount
  • 5R01CA254354-05R01Contact PI
    Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia
    Versiti Wisconsin, Inc.
    $369.9K
    award amount

Award organization

Organizations that administered FY2023 awards listing Deininger, Michael W. as a PI.

FY2023 award administered by Versiti Wisconsin, Inc. ().

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Versiti Wisconsin, Inc.
  2. 2007
    $500K Cumulative Funding
  3. 2009
    $1M Cumulative Funding
  4. 2009
    R01 Grant Holder
  5. 2021
    $2M Cumulative Funding
  6. 2021
    Entered Top 50% Nationally
    Ranked #9123
  7. 2023
    $5M Cumulative Funding

Explore further

Find collaborators for Deininger, Michael W.

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →